Literature DB >> 1431525

Adrenal suppression with intranasal betamethasone drops.

M D Flynn1, P Beasley, J E Tooke.   

Abstract

Intranasal betamethasone sodium phosphate drops (Betnesol) are frequently used to relieve nasal congestion due to polyposis. We report a case of significant hypothalamic-pituitary-adrenal suppression secondary to the long-term use of intranasal betamethasone drops. This case emphasizes that the topical application of potent corticosteroids may produce systemic effects.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1431525     DOI： 10.1017/s0022215100120997

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN： 0022-2151            Impact factor:   1.469


  4 in total

1.  Do topical ophthalmic corticosteroids suppress the hypothalmic-pituitary-adrenal axis in post-penetrating keratoplasty patients?

Authors:  S S Sandhu; J M Smith; M Doherty; A James; F C Figueiredo
Journal:  Eye (Lond)       Date:  2012-02-17       Impact factor: 3.775

2.  Iatrogenic Cushing's syndrome due to nasal betamethasone: a problem not to be sniffed at!

Authors:  C M Nutting; S R Page
Journal:  Postgrad Med J       Date:  1995-04       Impact factor: 2.401

3.  Iatrogenic Cushing's syndrome as a consequence of nasal use of Betamethasone spray during pregnancy.

Authors:  A Scutelnicu; A M Panaitescu; A M Ciobanu; N Gica; R Botezatu; G Peltecu; M L Gheorghiu
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Oct-Dec       Impact factor: 0.877

Review 4.  Restoration of olfactory dysfunctions by nanomaterials and stem cells-based therapies: Current status and future perspectives.

Authors:  Shin Hyuk Yoo; Hae-Won Kim; Jun Hee Lee
Journal:  J Tissue Eng       Date:  2022-03-23       Impact factor: 7.813
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.